Connexion
MON PANIER
|
+32 (0)2 352 07 80
Email
Aide

NEW INSIGHTS IN TYPE II INFLAMMATION IN SEVERE ASTHMA

Pour médecins et pharmaciens
Accréditation approuvée
1 Module - 1 Orateur
12 mois à partir du 07/12/2020
INTRODUCTION


Asthma is characterized by chronic inflammation of the airway.

Type 2 inflammation is present in 50%* of patients with severe asthma.

We will discuss the significant patient burden of disease and need for treatment options that address the actions of key inflammatory cytokines including IL-4, IL-5 and IL-13, which play a central role in contributing to the Type 2 inflammatory response.

*Peters MC et al. Measures of gene expression in sputum cells can identify TH2-high and TH2-low subtypes of asthma. J Allergy Clin Immunol. 2014;133(2):388–394. n=108/205

Pneumology : n° 20021706 (1,5 CP)
ORATEUR
Pr Bart Lambrecht
UZ Gent
PROGRAMME SCIENTIFIQUE

  • New Insights in Type II Inflammation in Severe Asthma
  • Q & A and conclusion
Organised by
With the kind support of
cogenvelopephone-handset